MoonLake Immunotherapeutics (MLTX)
Develops sonelokimab for inflammatory diseases including hidradenitis suppurativa and psoriatic arthritis.
$14.97
Pre-market−0.10 (−0.66%)
At close$15.07(−0.40%)
Something off on this page? Send us feedback.
Next report
Nov 4, 2026
estimated · in 62 days
EPS estimate
−$0.77
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.72−$0.63−$0.87−$1.10−$0.92−$0.98−$0.84Pending
Estimate−$0.53−$0.76−$0.73−$0.89−$0.92−$0.91−$0.91−$0.77
Surprise−35.8%+17.1%−19.2%−23.6%0.0%−7.7%+7.5%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$101.9K——————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.77 | — | — |
| Aug 2026 | −$0.92 | — | — |
| Aug 2026 | −$0.91 | −$0.84 | +7.5% |
| May 2026 | −$0.91 | −$0.98 | −7.7% |
| Feb 2026 | −$0.92 | −$0.92 | 0.0% |
| Nov 2025 | −$0.89 | −$1.10 | −23.6% |
The latest year is open to everyone — the 19 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.77 | — | — | — | — | — | — |
| Aug 11, 2026 | −$0.92 | — | — | — | — | — | — |
| Aug 10, 2026 | −$0.91 | −$0.84 | +7.5% | — | — | — | −5.1% |
| May 11, 2026 | −$0.91 | −$0.98 | −7.7% | — | — | — | −3.5% |
| Feb 25, 2026 | −$0.92 | −$0.92 | 0.0% | — | — | — | −3.0% |
| Nov 5, 2025 | −$0.89 | −$1.10 | −23.6% | — | — | — | −2.8% |
The latest year is open to everyone — the 19 quarters behind it read with an account. Sign in | |||||||
| Aug 5, 2025 | |||||||
| May 12, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 20, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 16, 2022 | |||||||
| Feb 17, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 21, 2021 | |||||||
| Mar 31, 2021 | |||||||